TY  - GEN
AU  - Brogan,Anita J
AU  - Talbird,Sandra E
AU  - Cohen,Calvin
TI  - Cost-effectiveness of nucleoside reverse transcriptase inhibitor pairs in efavirenz-based regimens for treatment-naïve adults with HIV infection in the United States
SN  - 1524-4733
PY  - 2011///1007
KW  - Adenine
KW  - analogs & derivatives
KW  - Adult
KW  - Alkynes
KW  - Anti-HIV Agents
KW  - economics
KW  - Antiretroviral Therapy, Highly Active
KW  - Benzoxazines
KW  - CD4 Lymphocyte Count
KW  - Clinical Trials as Topic
KW  - Cost Savings
KW  - Cost-Benefit Analysis
KW  - Cyclopropanes
KW  - Deoxycytidine
KW  - Dideoxynucleosides
KW  - Drug Costs
KW  - Emtricitabine
KW  - Female
KW  - HIV Infections
KW  - diagnosis
KW  - Health Services Research
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - Markov Chains
KW  - Models, Economic
KW  - Organophosphonates
KW  - Outcome and Process Assessment, Health Care
KW  - Quality-Adjusted Life Years
KW  - Reverse Transcriptase Inhibitors
KW  - Tenofovir
KW  - Time Factors
KW  - Treatment Outcome
KW  - United States
KW  - epidemiology
KW  - Viral Load
KW  - Zidovudine
N1  - Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jval.2011.01.009
ER  -